Ehtisham Mahmud1, Florian Schmid2, Peter Kalmar2, Hannes Deutschmann2, Franz Hafner3, Peter Rief3, Marianne Brodmann3. 1. Division of Cardiovascular Medicine, Sulpizio Cardiovascular Center, University of California, San Diego, La Jolla, California. Electronic address: emahmud@ucsd.edu. 2. Division of Interventional Radiology, Medical University, Graz, Austria. 3. Clinical Division of Angiologie, Medical University, Graz, Austria.
Abstract
OBJECTIVES: The goal of this study was to evaluate the feasibility and safety of a robotic-assisted platform (CorPath 200, Corindus Vascular Robotics, Waltham, Massachusetts) for treating peripheral artery disease. BACKGROUND: A robotic-assisted platform for percutaneous coronary intervention is available for treating coronary artery disease. METHODS: In this prospective single-arm trial, patients with symptomatic peripheral artery disease (Rutherford class 2 to 5) affecting the femoropoplital artery were enrolled. Endpoints evaluated were: 1) device technical success, defined as successful cannulation of the target vessel with the robotic system; 2) device safety, defined as absence of device related serious adverse event (hospitalization, prolonged hospitalization, life threatening, or resulted in death); and 3) clinical procedural success, defined as <50% residual stenosis without an unplanned switch to manual assistance or device-related serious adverse event in the periprocedural period. RESULTS: The study enrolled 20 subjects (65.5 ± 9.3 years of age; 70% male) with primarily Rutherford class 2 to 3 (90%) symptoms. A total of 29 lesions (lesion length: 33.1 ± 15.5 mm) were treated with the majority (89.7%) being located in the superficial femoral artery. Device technical success, safety and clinical procedural success were all 100% with provisional stenting required in 34.5% of lesions. Fluoroscopy time (7.1 ± 3.2 min) and contrast use (73.3 ± 9.2 ml) compared favorably with studies in similar patient cohorts. There were no adverse events associated with the use of the robotic system. CONCLUSIONS: These data demonstrate the feasibility and safety of using a robotic-assisted platform for performing peripheral arterial revascularization.
OBJECTIVES: The goal of this study was to evaluate the feasibility and safety of a robotic-assisted platform (CorPath 200, Corindus Vascular Robotics, Waltham, Massachusetts) for treating peripheral artery disease. BACKGROUND: A robotic-assisted platform for percutaneous coronary intervention is available for treating coronary artery disease. METHODS: In this prospective single-arm trial, patients with symptomatic peripheral artery disease (Rutherford class 2 to 5) affecting the femoropoplital artery were enrolled. Endpoints evaluated were: 1) device technical success, defined as successful cannulation of the target vessel with the robotic system; 2) device safety, defined as absence of device related serious adverse event (hospitalization, prolonged hospitalization, life threatening, or resulted in death); and 3) clinical procedural success, defined as <50% residual stenosis without an unplanned switch to manual assistance or device-related serious adverse event in the periprocedural period. RESULTS: The study enrolled 20 subjects (65.5 ± 9.3 years of age; 70% male) with primarily Rutherford class 2 to 3 (90%) symptoms. A total of 29 lesions (lesion length: 33.1 ± 15.5 mm) were treated with the majority (89.7%) being located in the superficial femoral artery. Device technical success, safety and clinical procedural success were all 100% with provisional stenting required in 34.5% of lesions. Fluoroscopy time (7.1 ± 3.2 min) and contrast use (73.3 ± 9.2 ml) compared favorably with studies in similar patient cohorts. There were no adverse events associated with the use of the robotic system. CONCLUSIONS: These data demonstrate the feasibility and safety of using a robotic-assisted platform for performing peripheral arterial revascularization.
Authors: Kazim H Narsinh; Ricardo Paez; Kerstin Mueller; M Travis Caton; Amanda Baker; Randall T Higashida; Van V Halbach; Christopher F Dowd; Matthew R Amans; Steven W Hetts; Alexander M Norbash; Daniel L Cooke Journal: Neuroradiol J Date: 2021-08-16
Authors: Pedro A Lemos; Marcelo Franken; Jose Mariani; Adriano Caixeta; Breno O Almeida; Fabio G Pitta; Guy F A Prado; Stefano Garzon; Felipe Ramalho; Gabriel Albuquerque; Ivanise M Gomes; Irisvaldo S de Oliveira; Leonardo Valle; Leonardo Galastri; Breno B Affonso; Felipe Nasser; Rodrigo G Garcia Journal: Cardiovasc Diagn Ther Date: 2022-02
Authors: Jean-François Dorval; Louis-Philippe Richer; Luc Soucie; Luke C McSpadden; Adam Hoopai; Stéphanie Tan; Nick E J West; E Marc Jolicoeur Journal: JACC Basic Transl Sci Date: 2021-11-05